What does clinical research consulting cover?
Clarenta’s clinical research consulting helps development teams work out what their programme needs, in what order, and what it will cost, before a protocol is written. We advise on non-clinical development, the quality and manufacturing questions that affect safety, regulatory strategy, trial design and clinical operations.
We work with biotech, specialty pharma, and medical device and combination product developers who need senior development experience without building every capability in-house.
Clarity, control and expertise where you need it
Strategic clarity
A development roadmap, gap analysis and regulatory position built around the next milestone.
Operational control
Timelines, risks, dependencies and delivery kept visible across the programme.
Embedded experts
Senior clinical, regulatory and non-clinical specialists working alongside your team when you need them.
When should you bring in a clinical development consultant?
The earlier we are involved, the more we can help you de-risk. We support teams at key development inflection points, bringing senior strategic and operational experience when decisions around strategy, budget, regulatory expectations and execution matter most.
Preclinical planning
Aligning the science with what regulators will expect
Defining the development roadmap
Identifying the risks that are hardest to reverse
Early development
Deliverables and budget planning
Scientific advice review
Programme readiness assessment
Clinical execution
Assessment of the partners involved
Oversight of execution
Gap analysis and early risk identification
Programme tracking and alignment
Regulatory interactions
Preparing and structuring the meeting
Aligning your package with what the regulator expects
Clinical development strategy
We start from your corporate strategy, your development stage, and the evidence your next milestone has to produce. From there we shape the development plan, study design, timelines, budget and regulatory sequence around the programme as a whole, so every study earns its place rather than only answering its own endpoint.
- Clinical development planning
- Protocol synopsis and study design
- Basket, adaptive and dose-escalation strategy
- Risk analysis
- Budget and timeline modelling
- Investor and board milestone planning
Clinical programme oversight
We provide senior clinical programme leadership where your internal resources are limited, or where a study already running needs stronger oversight. We keep the scientific intent, the operational reality, the timelines, the risks and the escalation points visible as the programme moves.
- Study and programme oversight
- Delivery against milestones
- Clinical gap analysis, in line with ICH E6(R3) expectations
- Risk assessment and mitigation
- Escalation pathways and study-status reporting
- Stakeholder coordination
Clinical operations support
For teams running a virtual model, or a team that is growing. We run day-to-day clinical operations or strengthen the team you already have. Our senior project managers stay close to the decisions as well as the execution, from study start-up through to close-out, including executive committees, board meetings and investigator meetings.
- Clinical project management
- Study start-up
- Timeline and budget management
- Site and stakeholder coordination
- Recruitment, training and upskilling of your team to GCP standards
- Scientific and medical writing
What happens when you get in touch
Step 1
First conversation
We understand what the product is, where it stands and what the next milestone needs to prove. Everything else follows from those answers.
Step 2
Assessment
We review what exists across non-clinical, regulatory and clinical development, and identify the gaps, dependencies and risks. Where risk sits, we say so, including where a regulator is likely to object.
Step 3
The plan
You receive the strategy, analysis or study plan needed to move the programme forward, with the reasoning behind it in a form your team can act on.